Published in Lancet on May 09, 1998
Case reports in an evidence-based world. J R Soc Med (1999) 3.55
Cerebral venous thrombosis: pathogenesis, presentation and prognosis. J R Soc Med (2000) 1.64
Risk of cerebral vein thrombosis and oral contraceptives. Lancet (1998) 1.18
Accuracy of CT angiography for the diagnosis of vascular abnormalities causing intraparenchymal hemorrhage in young patients. Emerg Radiol (2009) 1.03
Cerebral venous and sinus thrombosis associated with subcutaneous immunoglobulin injection and oral contraceptive use. Neurol Sci (2011) 0.77
Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis. Front Neurol (2015) 0.75
The Importance of Early Recognition of Cerebral Venous Sinus Thrombosis: A Case Report. Malays J Med Sci (2015) 0.75
Peripheral arterial disease in a female using high-dose combined oral contraceptive pills. Indian J Pharmacol (2013) 0.75
Cerebral venous thrombosis. Lancet (2001) 0.75
Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet (1994) 5.58
Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (1995) 5.10
Genetic influence on cytokine production and fatal meningococcal disease. Lancet (1997) 4.89
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation (1991) 4.37
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ (2009) 4.18
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med (1996) 4.11
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet (1995) 4.01
Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet (1992) 3.58
Case reports in an evidence-based world. J R Soc Med (1999) 3.55
Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke (1999) 3.42
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med (1990) 3.16
Is publication bias a medical problem? Lancet (1993) 3.04
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood (1995) 2.96
Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93
EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol (2010) 2.92
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med (1993) 2.70
Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ (1994) 2.54
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol (1993) 2.40
Osteoarthritis and obesity in the general population. A relationship calling for an explanation. J Rheumatol (1988) 2.39
Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol (1984) 2.38
Antipsychotic medication and venous thrombosis. Br J Psychiatry (2001) 2.37
Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet (1991) 2.31
Bungee-jumping and design of experiments. Lancet (1992) 2.31
Mortality in hereditary antithrombin-III deficiency--1830 to 1989. Lancet (1991) 2.31
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (1996) 2.30
New public health and old rhetoric. BMJ (1994) 2.18
Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet (1996) 2.14
Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) Blood (1995) 2.09
Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation (1990) 2.07
No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85-plus study. Eur J Clin Invest (2002) 2.07
Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07
Psychiatric disorders in relation to medical illness among patients of a general medical out-patient clinic. Psychol Med (1993) 2.01
Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum (1990) 2.01
Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands. Lancet (1996) 1.99
EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol (2006) 1.97
Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med (1999) 1.95
Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry (2001) 1.84
Prospective or retrospective: what's in a name? BMJ (1991) 1.82
Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol (1984) 1.75
Silent intracerebral microhemorrhages in patients with ischemic stroke. Amsterdam Vascular Medicine Group. Ann Neurol (1998) 1.75
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68
The Leiden Thrombophilia Study (LETS). Thromb Haemost (1997) 1.65
Should we abandon statistical modeling altogether? Am J Epidemiol (1987) 1.64
Thyroid diseases and cerebrovascular disease. Stroke (2005) 1.63
Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia (2002) 1.63
Usefulness of patient interview in bleeding disorders. Arch Intern Med (1995) 1.62
The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis (1983) 1.61
Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA (1986) 1.59
Pregnancy and severe aplastic anaemia: causal relation or coincidence? . Br J Haematol (1998) 1.56
Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr (2000) 1.53
Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med (1995) 1.52
The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum (1996) 1.50
The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol (1997) 1.48
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]. Internist (Berl) (2008) 1.47
Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab (2007) 1.47
Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) (1997) 1.46
In defense of Farr and Nightingale. Ann Intern Med (1996) 1.46
Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol (1992) 1.46
Competing interests and controversy about third generation oral contraceptives. BMJ readers should know whose words they read. BMJ (2000) 1.45
Retinal arterial changes correlate with cerebral small-vessel disease. Neurology (2002) 1.44
On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol (1991) 1.44
Maintaining privacy and the health of the public. Should not be seen as in opposition. BMJ (1998) 1.42
[Thrombosis of the cerebral veins and sinuses in 62 patients]. Ned Tijdschr Geneeskd (1995) 1.41
[Epoetin-induced pure red-cell aplasia]. Ned Tijdschr Geneeskd (2004) 1.41
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS). Thromb Haemost (1994) 1.41
[The thrombosis service as a source of information for studies in patients with heart valve prostheses]. Ned Tijdschr Geneeskd (1992) 1.40
Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Arch Dermatol (1997) 1.39
Mortality in patients with epilepsy: 40 years of follow up in a Dutch cohort study. J Neurol Neurosurg Psychiatry (1999) 1.39
[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]. Ned Tijdschr Geneeskd (2005) 1.39
[Physicians and scientific research: slight decline of the numbers of physicians with a doctoral degree]. Ned Tijdschr Geneeskd (2006) 1.39
Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res (1991) 1.39
[Neuroradiologic intervention in two patients with cerebral sinus thrombosis]. Ned Tijdschr Geneeskd (2000) 1.38
Prediction of osteoporotic fractures in the general population by a fracture risk score. A 9-year follow-up among middle-aged women. Am J Epidemiol (1990) 1.34
Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum (1990) 1.33
Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis (1994) 1.33
Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol (1985) 1.31
Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect. Lancet (1982) 1.29
Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet (2003) 1.25
Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med (2000) 1.25
Living with epilepsy: long-term prognosis and psychosocial outcomes. Neurology (2003) 1.25
Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis (1996) 1.23
Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol (1987) 1.22
Female hormones and thrombosis. Arterioscler Thromb Vasc Biol (2002) 1.20
A longitudinal study of back pain and radiological changes in the lumbar spines of middle aged women. I. Clinical findings. Ann Rheum Dis (1991) 1.20
Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum (1988) 1.18
Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol (1990) 1.18
Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain (1999) 1.17
Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining. Virchows Arch A Pathol Anat Histol (1982) 1.16
Parental survival, an independent predictor of longevity in middle-aged persons. Am J Epidemiol (1984) 1.15
Mechanical thrombectomy cannot be considered as first-line treatment for cerebral venous thrombosis. J Neurointerv Surg (2012) 1.15
Treatment variations in cerebral venous thrombosis: an international survey. Cerebrovasc Dis (2011) 1.15
Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res (1990) 1.14
Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum (1987) 1.13